Sophia Engelhard

Sophia Engelhard is a Researcher and Visitor in the Schéele Group at the Faculty of Health and Medical Sciences, University of Copenhagen, based at Blegdamsvej 3B, Mærsk Tårnet, 6. sal, 2200 København N. Her work focuses on hematopoietic stem cells and acute myeloid leukemia (AML) pathogenesis.

Her primary research interests include Hematology, Oncology, and Stem Cell Biology, with specialized expertise in transendothelial migration mechanisms, oxidative DNA damage response, and targeted AML therapies. She investigates molecular pathways involving endomucin, AKT signaling, and nucleotide sanitation to develop novel treatment strategies.

Analysis of her recent publications reveals a cohesive research trajectory centered on AML therapeutics and stem cell dynamics. Her 2021-2024 work demonstrates consistent collaboration with leading hematology researchers, emphasizing cooperative mutation responses and chemotherapy enhancement through molecular targeting.

As an active member of the Schéele Group, she contributes to experimental design and data interpretation in high-impact hematology research, with publications in Cell Reports, Molecular Cancer Therapeutics, and Leukemia reflecting significant contributions to the field.